Vol 67 No 6

June 28, 2022

Understanding signs, symptoms helps determine the best treatment regimen

June 07, 2022

This month we focus on pediatric adolescent gynecologic topics, which are critical to our practices (and our families).

June 03, 2022

Part 2 in a series on emergencies in pediatric and adolescent gynecology

June 03, 2022

Key financial metrics detail your practice’s economic health

June 02, 2022

Offering an inclusive, safe space along with the best care for transgender and nonbinary adolescent patients is more important than ever.

June 02, 2022

From COVID-19 to climate change to vulvovaginal candidiasis, the annual meeting offered something for everyone.

June 01, 2022

This year marks the 53rd anniversary of the Stonewall Uprising--the historic gay-rights demonstrations that broke out after police raided the Stonewall Inn on June 28, 1969, in Greenwich Village in New York, New York.

May 25, 2022

Interviews with mothers in the immediate postpartum period revealed that most decisions on breastfeeding and contraception were based on the personal experiences of participants and their friends and family.

April 29, 2022

The US Food and Drug Administration has approved oteseconazole (Vivjoa; Mycovia Pharmaceuticals) to reduce the incidence of recurrent vulvovaginal candidiasis.

April 27, 2022

The FDA recently issued a statement warning the public of the risks and potential false results obtained with noninvasive prenatal screening tests, noting that inappropriate usage and interpretation has resulted in improper medical decisions.

April 13, 2022

Women with laparoscopically confirmed endometriosis are at significantly higher risk for early natural menopause (ENM), and this risk was greater for nulliparous women and women who never reported using oral contraceptives, according to a study in JAMA Network Open.